Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inder Anand

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
American Heart Journal|January 6, 2005
Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)Lawrence Baruch, Robert D Glazer, Nora Aknay, et al.
European Heart Journal|February 27, 2004
The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFTRoberto Latini, Serge Masson, Inder Anand, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Post-Extrasystolic Potentiation as a Predictor of Recovery of Left Ventricular Dysfunction After Radiofrequency Catheter AblationBalaji Krishnan, Ashwini Sankar, Inder Anand, et al.
International Journal of Cardiology|October 20, 2006
Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFTHenry Krum, Roberto Latini, Aldo P Maggioni, et al.
JACC. Heart Failure|November 7, 2016
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-AnalysisAlberto Aimo, Giuseppe Vergaro, Claudio Passino, et al.
American Heart Journal|November 10, 2012
Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: rationale and designWilliam T Abraham, Inder Anand, Juan M Aranda, et al.
JACC. Heart Failure|October 17, 2017
Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT StudyAli Vazir, Brian Claggett, Bertram Pitt, et al.
Circulation|December 6, 2011
Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trialsSerge Masson, Inder Anand, Chiara Favero, et al.
Journal of the American Heart Association|June 29, 2022
Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator ChangesKenneth C Bilchick, Yongfei Wang, Jeptha P Curtis, et al.
Journal of the American College of Cardiology|December 6, 2005
Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trialBradley A Bart, Andrew Boyle, Alan J Bank, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
American Heart Journal|January 6, 2005
Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)Lawrence Baruch, Robert D Glazer, Nora Aknay, et al.
European Heart Journal|February 27, 2004
The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFTRoberto Latini, Serge Masson, Inder Anand, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Post-Extrasystolic Potentiation as a Predictor of Recovery of Left Ventricular Dysfunction After Radiofrequency Catheter AblationBalaji Krishnan, Ashwini Sankar, Inder Anand, et al.
International Journal of Cardiology|October 20, 2006
Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFTHenry Krum, Roberto Latini, Aldo P Maggioni, et al.
JACC. Heart Failure|November 7, 2016
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-AnalysisAlberto Aimo, Giuseppe Vergaro, Claudio Passino, et al.
American Heart Journal|November 10, 2012
Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: rationale and designWilliam T Abraham, Inder Anand, Juan M Aranda, et al.
JACC. Heart Failure|October 17, 2017
Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT StudyAli Vazir, Brian Claggett, Bertram Pitt, et al.
Circulation|December 6, 2011
Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trialsSerge Masson, Inder Anand, Chiara Favero, et al.
Journal of the American Heart Association|June 29, 2022
Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator ChangesKenneth C Bilchick, Yongfei Wang, Jeptha P Curtis, et al.
Journal of the American College of Cardiology|December 6, 2005
Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trialBradley A Bart, Andrew Boyle, Alan J Bank, et al.
Pageof 11